Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.5%

3 terminated/withdrawn out of 26 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

23%

6 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 1
4(25.0%)
N/A
4(25.0%)
Phase 3
3(18.8%)
Phase 4
3(18.8%)
Phase 2
2(12.5%)
16Total
Phase 1(4)
N/A(4)
Phase 3(3)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT04864171Recruiting

REASSURE-NIRS Registry

Role: lead

NCT03729232Recruiting

Japanese Catheter Ablation Registry

Role: lead

NCT04345627Recruiting

Japanese Lead Extraction Registry

Role: lead

NCT02889653Completed

The Bleeding With Antithrombotic Therapy Study 2

Role: lead

NCT02251665Active Not Recruiting

National Cerebral and Cardiovascular Center (NCVC) Stroke Registry

Role: lead

NCT06072118Phase 2Completed

Adrenomedullin for CADASIL

Role: lead

NCT03591328Unknown

Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study

Role: collaborator

NCT01273857Phase 1Completed

Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology

Role: collaborator

NCT02491268Phase 2Completed

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

Role: lead

NCT04559191Phase 4Unknown

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

Role: lead

NCT02455830Unknown

Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02256618Phase 1Completed

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02907229Not ApplicableCompleted

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms

Role: lead

NCT02002325Phase 3Unknown

THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

Role: lead

NCT00212017Not ApplicableTerminated

Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT

Role: lead

NCT02449330Phase 4Unknown

Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study

Role: lead

NCT00212004Phase 4Terminated

Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

Role: lead

NCT01176565Phase 3Terminated

Antihypertensive Treatment of Acute Cerebral Hemorrhage-II

Role: collaborator

NCT02801708Unknown

Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source

Role: lead

NCT00361530Phase 3Completed

Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)

Role: collaborator